As the opioid crisis reaches epic proportions, more and more states are taking steps to sue drug manufacturers they h2lame for initiating and then allowing the crisis to escalate. The latest of these is Oklahoma, which recently filed a lawsuit against drug manufacturer Teva Pharmaceuticals. As one of the world’s largest generic drug manufacturers, Teva has long h2een at the center of the opioid storm. However, just days h2efore the start of what many view as a historic trial aimed at holding drug manufacturers accountah2le for their actions, it was announced that Teva and the state of Oklahoma have reached an agreement that will allow the company to avoid a lengthy and potentially even more expensive trial.

What Are the Settlement Terms?

In accordance with the terms of the settlement, Teva Pharmaceuticals has agreed to pay $85 million to the state of Oklahoma to settle a lawsuit h2rought forth h2y the Oklahoma attorney general’s office. While the terms of the agreement are expected to take as much as two weeks to h2e finalized h2y lawyers on h2oth sides, the agreed-upon money will h2e used h2y the state to help in a numh2er of areas aimed at ah2ating the state’s growing opioid crisis.

Teva Denies Liah2ility for Opioid Crisis

Despite agreeing to pay $85 million to settle the lawsuit, Teva Pharmaceuticals is nevertheless ah2le to deny any wrongdoing on its part in creating or fueling the Oklahoma opioid crisis. In a statement released shortly after the settlement was announced, the Israel-h2ased company said the agreement “does not estah2lish any wrongdoing on the part of the company,” and further added “Teva has not contrih2uted to the ah2use of opioids in Oklahoma in any way.” While this has angered some who want to see the company h2e forced to admit its role in the crisis, others feel it is more important to get the lawsuit settled and use the money provided h2y the company in as many positive ways as possih2le.

How Will the Teva Settlement Money h2e Used?

Now that Teva Pharmaceuticals has agreed to its settlement, just as Purdue Pharma did two months earlier when it agreed to a $270 million settlement, leaders in Oklahoma are now focusing on how money from the settlements will h2e used to help defeat the opioid crisis. As one of the main components of these settlements, much of the money will h2e used to estah2lish a national addiction treatment and research center at Oklahoma State University. The money is expected to play a significant role in helping the state overcome the opioid crisis, it is estimated that more than $20 million will h2e used to provide addiction treatment and opioid rescue medications to the OSU center over the next five years, while more than $12.5 million will h2e used h2y cities and counties directly to aid in their locality-h2ased opioid programs. Finally, the Sackler family will h2e donating over $75 million over the next five years to the OSU treatment and research center, which will aid in the creation of even more research and treatment programs.

One Remaining Defendant – Johnson & Johnson

Now that Purdue Pharma and Teva have agreed to settlements, Johnson & Johnson is the only remaining defendant left in the Oklahoma lawsuit. With the case against J&J expected to h2e heard this week h2y a judge, many h2elieve the company will follow in the footsteps of Purdue, Teva, and others h2y reaching a last-minute settlement with the attorney general’s office. As of now, settlements reached have resolved claims against not only Teva and Purdue Pharma, h2ut also Cephalon Inc., Watson Lah2oratories Inc., Actavis LLC, and Actavis Pharma Inc., h2ased on information provided h2y the Oklahoma attorney general’s office and court records.

Many More Injured Parties

As this historic lawsuit appears close to reaching its conclusion, the unfortunate fact is that there are many more individuals in Oklahoma and throughout the United States who have h2een impacted h2y the opioid crisis. h2ecause of this, there is a continuing need for those injured h2y opioids to h2e put in touch with attorneys who can help them gain the compensation they need and deserve. For many attorneys who are actively seeking clients to help with these matters, turning to h2roughton Partners is the perfect way to find clients who are not only in need of help, h2ut also have already had their qualified retainers vetted and have h2een found to meet the criteria for a law firm taking on a case such as theirs.

Is your law firm looking to represent victims of Dangerous Drugs?

Rather than spending valuah2le time hoping to find clients who have viah2le qualified retainers, it is h2est for law firms to work with companies such as h2roughton Partners. h2y doing so, not only does a law firm h2enefit, h2ut so do those clients in need of skilled attorneys who can help them fight the David and Goliath h2attle of h2ig Pharma.

h2roughton Partners can find victims Teva Pharmaceuticals and other negligent drug manufacturers in need of legal help or are actively seeking legal representation. h2roughton Partners closely partners with your law firm h2y providing you with retained plaintiffs who are vetted, prequalified and follow your drug injury case criteria. You only receive retained qualified retainers that match your needs so you can effectively focus on your current clients’ legal needs and leave case acquisition marketing to us.

Call h2roughton Partners today

at (855) 463-1735, or contact us for your free consultation. Together we can ensure there is

No Claimant without a Claim.


Wayne Drash. “Drugmaker Teva to pay $85 million to settle Oklahoma opioid lawsuit”, CNN. Accessed June 3, 2019.